{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T03:10:02Z","timestamp":1685761802578},"reference-count":43,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1827,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2893.2010.01334.x","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T04:15:12Z","timestamp":1283314512000},"page":"542-548","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis"],"prefix":"10.1111","volume":"18","author":[{"given":"L.","family":"Mart\u00edn-Carbonero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vispo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Labarga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gonz\u00e1lez-Lahoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,31]]},"reference":[{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the HIV: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/QAD.0b013e3281084e4d","article-title":"Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel","volume":"21","author":"Soriano","year":"2007","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C","volume":"20","author":"The METAVIR Cooperative Group","year":"1994","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB6|cit6","first-page":"1206","article-title":"Progression of hepatitis B and C to hepatocellular carcinoma in Western countries","volume":"45","author":"Fattovich","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep.510290424","article-title":"The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States","volume":"29","author":"Hu","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20626","article-title":"HIV coinfection shortens the survival of patients with hepatitis C virus related decompensated cirrhosis","volume":"41","author":"Pineda","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","article-title":"Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome","volume":"18","author":"Puoti","year":"2004","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","article-title":"Fast fibrosis progression between repeated liver biopsies in patients coinfected with HIV\/hepatitis C virus","volume":"50","author":"Mac\u00edas","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/135965350601100706","article-title":"Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV\/HIV coinfected patients","volume":"11","author":"Barreiro","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virological response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2036.2008.03639.x","article-title":"The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C antiviral long term treatment against cirrhosis trial","volume":"27","author":"Everson","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.23020","article-title":"Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with HIV and hepatitis C virus","volume":"50","author":"Berenguer","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-\u03b12a and ribavirin combination in chronic hepatitis C","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Inter Med"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/aid.2007.0011","article-title":"Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial","volume":"23","author":"Nu\u00f1ez","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"35","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/135965350801300404","article-title":"Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha 2a or alpha 2b","volume":"13","author":"Vispo","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Castera","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.qai.0000194238.15831.c7","article-title":"Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV\/hepatitis C virus-coinfected patients","volume":"41","author":"de Ledinghen","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"J Community Health"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1080\/00365540600786515","article-title":"Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C","volume":"38","author":"Mocroft","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"HIV infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis","volume":"26","author":"Soto","year":"1997","journal-title":"J Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/380130","article-title":"Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C: a European collaborative study","volume":"38","author":"Mart\u00edn-Carbonero","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1086\/605676","article-title":"Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients","volume":"49","author":"Pineda","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/QAD.0b013e3283366602","article-title":"Survival of HIV-infected patients with compensated liver cirrhosis","volume":"24","author":"Tuma","year":"2010","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","article-title":"Peginterferon-alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV co-infected persons","volume":"35","author":"Chung","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/MCG.0b013e318046ea75","article-title":"Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis","volume":"42","author":"Floreani","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1542-3565(04)00002-3","article-title":"Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis","volume":"2","author":"Fontana","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep.20793","article-title":"Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy","volume":"42","author":"Everson","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/135965350400900616","article-title":"Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies","volume":"9","author":"Soriano","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/00002030-200409030-00002","article-title":"Risk factors for hepatic decompensation in patients with HIV\/HCV coinfection and liver cirrhosis during interferon-based therapy","volume":"18","author":"Mauss","year":"2004","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis","volume":"343","author":"Heathcote","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography: a prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1086\/521857","article-title":"The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection","volume":"45","author":"Vergara","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/597350","article-title":"Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection","volume":"48","author":"Kirk","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB41|cit41","article-title":"Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C","author":"Cobbold","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/506440","article-title":"Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase","volume":"43","author":"S\u00e1nchez-Conde","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01334.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2893.2009.01133.x","article-title":"Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection","volume":"16","author":"Martin-Carbonero","year":"2009","journal-title":"J Viral Hepat"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01334.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2010.01334.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T02:44:09Z","timestamp":1685760249000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2010.01334.x"}},"subtitle":["Hepatitis C therapy in coinfected cirrhotics"],"short-title":[],"issued":{"date-parts":[[2010,8,31]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01334.x","relation":{},"ISSN":["1352-0504"],"issn-type":[{"value":"1352-0504","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,31]]}}}